Lupusa nefrito (Esperanto Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lupusa nefrito" in Esperanto language version.

refsWebsite

Global rank Esperanto rank

56doi.org

2^nd place

7^th place

37nih.gov

4^th place

9^th place

10ima-press.net

low place

1,634^th place

7bmj.com

1,226^th place

966^th place

6wiley.com

222^nd place

188^th place

2duke.edu

1,880^th place

1,403^rd place

2jrheum.org

low place

2oup.com

485^th place

437^th place

1lww.com

2,769^th place

2,262^nd place

1cdc.gov

218^th place

212^th place

1rmj.ru

9,799^th place

low place

1researchgate.net

120^th place

148^th place

1nature.com

234^th place

108^th place

1cyberleninka.ru

475^th place

low place

1rusvrach.ru

low place

1vrachjournal.ru

low place

1mdpi.com

2,912^th place

6,895^th place

1kidney-international.org

low place

1mediasphera.ru

low place

1plos.org

2,112^th place

1,162^nd place

1regionh.dk

low place

1mediar-press.net

low place

1springer.com

274^th place

260^th place

bmj.com

ard.bmj.com

Bertsias, George K.; Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frederic A Houssiau, John P A Ioannidis, David A Isenberg, Cees G M Kallenberg, Liz Lightstone, Stephen D Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimir Tesar, Carlos Vasconcelos, Ronald F van Vollenhoven, Helena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T Boumpas; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012-11). “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Alirita 2023-03-22..
(2012-11) “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Alirita 2023-03-27..
Tamirou, Farah; David D'Cruz, Shirish Sangle, Philippe Remy, Carlos Vasconcelos, Christoph Fiehn, Maria del Mar Ayala Guttierez, Inge-Magrethe Gilboe, Maria Tektonidou, Daniel Blockmans, Isabelle Ravelingien, Véronique le Guern, Geneviève Depresseux, Loïc Guillevin, Ricard Cervera, Frédéric A Houssiau; MAINTAIN Nephritis Trial Group (2016-03). “Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis”, Annals of Rheumatic Diseases (en), p. 526–531. doi:10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10. Alirita 2023-04-05..
Bertsias, George K.; Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frederic A Houssiau, John P A Ioannidis, David A Isenberg, Cees G M Kallenberg, Liz Lightstone, Stephen D Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimir Tesar, Carlos Vasconcelos, Ronald F van Vollenhoven, Helena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T Boumpas; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012-11). “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Alirita 2023-04-05..
Stummvoll, G.; M Aringer, J Smolen, S Schmaldienst, E Jimenez-Boj, W Horl, W Graninger, K Derfler (2005-07). “IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study”, Annals of Rheumatic Diseases (en) 64 (7), p. 1015–1021. doi:10.1136/ard.2004.029660. Alirita 2023-04-06..

lupus.bmj.com

Tamirou, Farah; Bernard R Lauwerys, Maria Dall'Era, Meggan Mackay, Brad Rovin, Ricard Cervera, Frédéric A Houssiau; MAINTAIN Nephritis Trial Investigators (2015-11-12). “A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial”, Lupus Science & Medicine (en) 2 (1), p. e000123. doi:10.1136/lupus-2015-000123. eCollection 2015. Alirita 2023-04-05..
Dall'Era, Maria; Victoria Levesque, Neil Solomons, Matt Truman, David Wofsy (2015-05-20). “Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome”, Lupus Science & Medicine (en) 2 (1), p. e000089. doi:10.1136/lupus-2015-000089. eCollection 2015. Alirita 2023-04-05..

cdc.gov

(1999-06-25) “Renal Insufficiency and Failure Associated with Immune Globulin Intravenous Therapy -- United States, 1985-1998”, Morbidity and Mortality Weekly Report (en) 48 (24), p. 518–521. Alirita 2023-03-23..

cyberleninka.ru

Насонов, Е.Л.; Решетняк Т.М., Денисов Л.Н. и др. (2012). “Белимумаб: прогресс в лечении системной красной волчанки”, Научно-практическая ревматология (ru) 50 (5), p. 13–19. Alirita 27-08-2020..

doi.org

Bastian, H. M.; J. M. Roseman, G. McGwin Jr., G. S. Alarcón, A. W. Friedman, B. J. Fessler, B. A. Baethge, J. D. Reveille (2002). “Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis”, Lupus (en) 11 (3), p. 152–160. doi:10.1191/0961203302lu158oa. Alirita 2023-03-17..
Jakes, Rupert W.; Sang-Cheol Bae, Worawit Louthrenoo, Chi-Chiu Mok, Sandra V. Navarra, Namhee Kwon (2012-02). “Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality”, Arthritis Care & Research (en) 64 (2), p. 159–168. doi:10.1002/acr.20683. Alirita 2023-03-17..
Панафидина, Т.А.; Попкова Т.В. (2018). “Общие принципы лечения волчаночного нефрита с профилактикой сердечно-сосудистых осложнений”, Современная ревматологи (ru) 12 (4), p. 4. doi:10.14412/1996-7012-2018-4-4-8. Alirita 2023-03-22..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 18–19. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 18–19. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Wakasugi, Daisuke; Takahisa Gono, Yasushi Kawaguchi, Masako Hara, Yumi Koseki, Yasuhiro Katsumata, Masanori Hanaoka, Hisashi Yamanaka (2012-01). “Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures” (en) 39 (1), p. 79–85. doi:10.3899/jrheum.110532. Alirita 2023-03-17..
Olson, Stephen W.; Jessica J Lee, Lisa K Prince, Thomas P Baker, Patricia Papadopoulos, Jess Edison, Kevin C Abbott (2013-10). “Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis”, Clinical Nephrology (en) 8 (10), p. 1702–1708. doi:10.2215/CJN.01910213. Alirita 2023-03-17..
Stojan, G.; M Petri (2016-07). “Anti-C1q in systemic lupus erythematosus”, Lupus (en) 25 (8), p. 873–877. doi:10.1177/0961203316645205. Alirita 2023-03-17..
Weixin, Hu; Yinghua Chen, Shaofan Wang, Hao Chen, Zhengzhao Liu, Caihong Zeng, Haitao Zhang, Zhihong Liu (2016-04-07). “Clinical-Morphological Features and Outcomes of Lupus Podocytopathy”, Clinical Nephrology (en) 11 (4), p. 585–592. doi:10.2215/CJN.06720615. Alirita 2023-03-17..
Di, Song; Li-hua Wu, Feng-mei Wang, Xiao-wei Yang, Di Zhu, Min Chen, Feng Yu, Gang Liu, Ming-hui Zhao (2013-01-15). “The spectrum of renal thrombotic microangiopathy in lupus nephritis”, Arthritis research & therapy (en) 15 (1). doi:10.1186/ar4142. Alirita 2023-03-17..
Bernatsky, S.; J-F Boivin, L Joseph, S Manzi, E Ginzler, D D Gladman, M Urowitz, P R Fortin, M Petri, S Barr, C Gordon, S-C Bae, D Isenberg, A Zoma, C Aranow, M-A Dooley, O Nived, G Sturfelt, K Steinsson, G Alarcón, J-L Senécal, M Zummer, J Hanly, S Ensworth, J Pope, S Edworthy, A Rahman, J Sibley, H El-Gabalawy, T McCarthy, Y St Pierre, A Clarke, R Ramsey-Goldman (2006 (Aŭgusto)). “Mortality in systemic lupus erythematosus”, Arthritis & Rheumatology (en) 54 (8). doi:10.1002/art.21955. Alirita 2023-03-17..
Лила, В.А. (2020). “Клинико-лабораторные взаимосвязи у пациентов с различными вариантами течения системной красной волчанки”, Современная ревматология (ru) (1), p. 26. doi:10.14412/1996-7012-2020-1-26-31. Alirita 20-08-2020..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 19–20. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 20. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Almaani, Salem; Alexa Meara, Brad H Rovin (2017-05-08). “Update on Lupus Nephritis”, Clinical Journal of the American Society of Nephrology (en) 12 (5), p. 825–835. doi:10.2215/CJN.05780616. Epub 2016 Nov 7. Alirita 2023-03-27..
Панафидина, Т.А.; Попкова Т.В. (2018). “Общие принципы лечения волчаночного нефрита с профилактикой сердечно-сосудистых осложнений”, Современная ревматологи (ru) 12 (4), p. 5. doi:10.14412/1996-7012-2018-4-4-8. Alirita 2023-03-22..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология 2 (3), p. 21. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Bertsias, George K.; Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frederic A Houssiau, John P A Ioannidis, David A Isenberg, Cees G M Kallenberg, Liz Lightstone, Stephen D Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimir Tesar, Carlos Vasconcelos, Ronald F van Vollenhoven, Helena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T Boumpas; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012-11). “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Alirita 2023-03-22..
Панафидина, Т.А.; Попкова Т.В. (2018). “Общие принципы лечения волчаночного нефрита с профилактикой сердечно-сосудистых осложнений”, Современная ревматологи (ru) 12 (4), p. 6. doi:10.14412/1996-7012-2018-4-4-8. Alirita 2023-03-22..
Лила, А.М.; Трофимов Е.А., Лила В.А. (2015). “Системная красная волчанка: особенности течения у беременных и варианты терапии”, Современная ревматология (ru) 9 (3), p. 45. doi:10.14412/1996-7012-2015-3-43-47. Alirita 20-08-2020..
van Vollenhoven, Ronald; M. J. Soto, M. J. Cuadrado, M. A. Khamashta (10-2011). “Rituximab — Shadow, illusion or light?”, Autoimmunity reviews (en) (11(8)), p. 563–567. doi:10.1016/j.autrev.2011.10.013. Alirita 27-08-2020..
Ramos-Casals, Manuel; M. J. Soto, M. J. Cuadrado, M. A. Khamashta (08-2009). “Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases”, Lupus (en) (18(9)), p. 767–776. doi:10.1177/0961203309106174. Alirita 27-08-2020..
Stohl, William; David M. Hilbert (9-01-2012). “The discovery and development of belimumab: the anti-BLyS-lupus connection”, Nature Biotechnology (en) 30 (1), p. 69–77. doi:10.1038/nbt.2076. Alirita 27-08-2020..
Halpern, Wendy G.; Patrick Lappin, Thomas Zanardi, Wendy Cai, Marta Corcoran, John Zhong, Kevin P. Baker (06-2006). “Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects”, Toxicological Sciences (en) 91 (2), p. 586–599. doi:10.1093/toxsci/kfj148. Alirita 27-08-2020..
Navarra, Sandra V.; Renato M. Guzmán, Alberto E. Gallacher, Stephen Hall, Roger A. Levy, Renato E. Jimenez, Edmund K.-M. Li, Mathew Thomas, Ho-Youn Kim, Manuel G. León, Coman Tanasescu, Eugeny Nasonov, Joung-Liang Lan, Lilia Pineda, Z John Zhong, William Freimuth, Michelle A. Petri, BLISS-52 Study Group (26-02-2011). “Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial”, The Lancet (en) 377 (9767), p. 721–731. doi:10.1016/S0140-6736(10)61354-2. Alirita 27-08-2020..
Furie, Richard; Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sanchez‐Guerrero, Andreas Schwarting, Joan T. Merrill, W. Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William Freimuth, Ronald F. van Vollenhoven, BLISS‐76 Study Group (12-2011). “A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus†”, Arthritis & Rheumatology (en) 63 (12), p. 3918–3930. doi:10.1002/art.30613. Alirita 27-08-2020..
Клюквина, Н.Г. (2013). “Опыт длительного применения белимумаба у больного системной красной волчанкой (описание случая)”, Современная ревматология (ru) 7 (2), p. 62–65. doi:10.14412/1996-7012-2013-2384. Alirita 20-08-2020..
Панафидина, Т.А.; Попкова Т.В. (2018). “Общие принципы лечения волчаночного нефрита с профилактикой сердечно-сосудистых осложнений”, Современная ревматологи (ru) 12 (4), p. 7. doi:10.14412/1996-7012-2018-4-4-8. Alirita 2023-03-22..
Charlesworth, John A; David M Gracey, Bruce A Pussell (2008-02). “Adult nephrotic syndrome: non-specific strategies for treatment” (en) 13 (1), p. 45–50. doi:10.1111/j.1440-1797.2007.00890.x. Alirita 2023-03-24..
Duffy, Margaret; Shashank Jain, Nicholas Harrell, Neil Kothari, Alluru S Reddi (2015-10-07). “Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies”, Cells (en) 4 (4), p. 622–630. doi:10.3390/cells4040622. Alirita 2023-03-24..
Rabelink, T J; J J Zwaginga, H A Koomans, J J Sixma (1994-08). “Thrombosis and hemostasis in renal disease”, Kidney International (en) 46 (2), p. 287–296. doi:10.1038/ki.1994.274. Alirita 2023-03-24..
Aviña-Zubieta, J Antonio; Fergus To, Kateryna Vostretsova, Mary De Vera, Eric C Sayre, John M Esdaile (2017-06). “Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study”, Arthritis Care Res (Hoboken) (en) 69 (6), p. 849–856. doi:10.1002/acr.23018. Epub 2017 May 9. Alirita 2023-03-24..
Tselios, Konstantinos; Dafna D Gladman, Jiandong Su, Olga Ace, Murray B Urowitz (2017-12). “Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study”, The Journal of Rheumatology (en) 44 (12), p. 1841–1849. doi:10.3899/jrheum.161121. Epub 2017 Nov 1. Alirita 2023-03-24..
Насонов, Е.Л.; Попкова Т.В., Новикова Д.С. (2016). “Сердечно-сосудистая патология при ревматических заболеваниях”, Терапевтический архив (ru) 88 (5), p. 4–12. doi:10.17116/terarkh20168854-12. Alirita 2023-03-24..
Gustafsson, Johanna T.; Marie Herlitz Lindberg, Iva Gunnarsson, Susanne Pettersson, Kerstin Elvin, John Öhrvik, Anders Larsson, Kerstin Jensen-Urstad, Elisabet Svenungsson (2017). “Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls”, PLOS ONE (en) 12 (4). doi:10.1371/journal.pone.0174572. Alirita 2023-03-24..
Hermansen, Marie-Louise; Jesper Lindhardsen, Christian Torp-Pedersen, Mikkel Faurschou, Søren Jacobsen (2017). “The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study”, Rheumatology (Oxford, England) (en) 56 (5), p. 709–715. doi:10.1093/rheumatology/kew475. Alirita 2023-03-24..
Панафидина, Т.А.; Попкова Т.В. (2018). “Общие принципы лечения волчаночного нефрита с профилактикой сердечно-сосудистых осложнений”, Современная ревматологи (ru) 12 (4), p. 7–8. doi:10.14412/1996-7012-2018-4-4-8. Alirita 2023-03-22..
(2012-11) “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Alirita 2023-03-27..
Козловская, Н. Л.; С. К. Соловьев, Е. А. Асеева, Т. В. Попкова, Т. А. Панафидина, Е. Л. Насонов, А. М. Лила, А. А. Меснянкина, Н. Ю. Никишина (2020). “Обновленные рекомендации EULAR/ERA–EDTA 2019 г. по терапии волчаночного нефрита. Комментарии экспертов. Часть I” (ru) 14 (4), p. 8. doi:10.14412/1996-7012-2020-4-7-15. Alirita 2023-03-27..
Dall'Era, Maria; Miriam G Cisternas, Dawn E Smilek, Laura Straub, Frédéric A Houssiau, Ricard Cervera, Brad H Rovin, Meggan Mackay (2015-05). “Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort”, Arthritis & Rheumatology (en) 67 (5), p. 1305–1313. doi:10.1002/art.39026. Alirita 2023-04-05..
Tamirou, Farah; David D'Cruz, Shirish Sangle, Philippe Remy, Carlos Vasconcelos, Christoph Fiehn, Maria del Mar Ayala Guttierez, Inge-Magrethe Gilboe, Maria Tektonidou, Daniel Blockmans, Isabelle Ravelingien, Véronique le Guern, Geneviève Depresseux, Loïc Guillevin, Ricard Cervera, Frédéric A Houssiau; MAINTAIN Nephritis Trial Group (2016-03). “Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis”, Annals of Rheumatic Diseases (en), p. 526–531. doi:10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10. Alirita 2023-04-05..
Tamirou, Farah; Bernard R Lauwerys, Maria Dall'Era, Meggan Mackay, Brad Rovin, Ricard Cervera, Frédéric A Houssiau; MAINTAIN Nephritis Trial Investigators (2015-11-12). “A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial”, Lupus Science & Medicine (en) 2 (1), p. e000123. doi:10.1136/lupus-2015-000123. eCollection 2015. Alirita 2023-04-05..
Mackay, Meggan; Maria Dall'Era, Joanna Fishbein, Kenneth Kalunian, Martin Lesser, Jorge Sanchez-Guerrero, Deborah M Levy, Earl Silverman, Michelle Petri, Cristina Arriens, Edmund J Lewis, Stephen M Korbet, Fabrizio Conti, Vladimir Tesar, Zdenka Hruskova, Eduardo F Borba, Eloisa Bonfa, Tak Mao Chan, Manish Rathi, K L Gupta, Vivekanand Jha, Sarfaraz Hasni, Melissa R West, Neil Solomons, Frederic A Houssiau, Juanita Romero-Diaz, Juan Mejia-Vilet, Brad H Rovin (2019-03). “Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes”, Arthritis & Rheumatology (en) 71 (3), p. 411–419. doi:10.1002/art.40724. Epub 2019 Feb 1. Alirita 2023-04-05..
Dall'Era, Maria; David Stone, Victoria Levesque, Miriam Cisternas, David Wofsy (2011-03). “Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide”, Arthritis Care Res (Hoboken) (en) 63 (3), p. 351–357. doi:10.1002/acr.20397. Epub 2010 Nov 15. Alirita 2023-04-05..
Dall'Era, Maria; Victoria Levesque, Neil Solomons, Matt Truman, David Wofsy (2015-05-20). “Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome”, Lupus Science & Medicine (en) 2 (1), p. e000089. doi:10.1136/lupus-2015-000089. eCollection 2015. Alirita 2023-04-05..
Touma, Zahi; Murray B Urowitz, Dominique Ibañez, Dafna D Gladman (2014-04). “Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment”, The Journal of Rheumatology (en) 41 (4), p. 688–697. doi:10.3899/jrheum.130005. Epub 2014 Jan 15. Alirita 2023-04-05..
Padmanabhan, Anand; Laura Connelly-Smith, Nicole Aqui, Rasheed A Balogun, Reinhard Klingel, Erin Meyer, Huy P Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D Zantek, Nancy M Dunbar, Guest Editor Joseph Schwartz (2019-06). “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue”, The Journal of Clinical Apheresis (en) 34 (3), p. 171–354. doi:10.1002/jca.21705. Alirita 2023-04-05..
Bertsias, George K.; Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frederic A Houssiau, John P A Ioannidis, David A Isenberg, Cees G M Kallenberg, Liz Lightstone, Stephen D Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimir Tesar, Carlos Vasconcelos, Ronald F van Vollenhoven, Helena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T Boumpas; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012-11). “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Alirita 2023-04-05..
Соколов, А. А.; А. С. Мануилов, С. Н. Бардаков, В. В. Тишко, А. Н. Бельских, О. Ю. Стрельникова, Т. В. Булгакова (2020). “Программная иммуносорбция с регенерацией сорбционных колонок при лечении волчаночного нефрита”, Современная ревматология (ru) 14 (3), p. 112. doi:10.14412/1996-7012-2020-3-111-116. Alirita 2023-04-05..
Асеева, Е. А.; С. К. Соловьев, Т. В. Попкова, Н. Ю. Никишина, А. А. Меснянкина (2019). “Ведение пациентов с системной красной волчанкой в реальной клинической практике”, Научно-практическая ревматология (ru) 57 (2), p. 194. doi:10.14412/1995-4484-2019-191-196. Alirita 2023-04-05..
Li, MinXia; YuanDa Wang, Qiang Qiu, RiBao Wei, YuWei Gao, Li Zhang, Yong Wang, XueGuang Zhang, XiangMei Chen (2016-08). “Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis”, The Journal of Clinical Apheresis (en) 31 (4), p. 375–380. doi:10.1002/jca.21408. Epub 2015 May 28. Alirita 2023-04-05..
Yamaji, Ken; Young-Joon Kim, Hiroshi Tsuda, Yoshinari Takasaki (2008-08). “Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis”, Therapeutic Apheresis and Dialysis (en) 12 (4), p. 298–305. doi:10.1111/j.1744-9987.2008.00591.x. Alirita 2023-04-06..
Stefanutti, Claudia; Antonio Vivenzio, Serafina Di Giacomo, Maura Mareri, Fulvia Ceccarelli, Guido Valesini (2005). “Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone”, BioDrugs (en) 19 (2), p. 129–133. doi:10.2165/00063030-200519020-00004. Alirita 2023-04-06..
Braun, N.; C Erley, R Klein, I Kötter, J Saal, T Risler (2000-09). “Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus”, Nephrology Dialysis Transplantation (en) 15 (9), p. 1367–1372. doi:10.1093/ndt/15.9.1367. Alirita 2023-04-06..
Stummvoll, Georg H.; Sabine Schmaldienst, Josef S Smolen, Kurt Derfler, Peter Biesenbach (2012-02). “Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity”, Nephrology Dialysis Transplantation (en) 27 (2), p. 618–626. doi:10.1093/ndt/gfr239. Epub 2011 May 26. Alirita 2023-04-06..
Stummvoll, G.; M Aringer, J Smolen, S Schmaldienst, E Jimenez-Boj, W Horl, W Graninger, K Derfler (2005-07). “IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study”, Annals of Rheumatic Diseases (en) 64 (7), p. 1015–1021. doi:10.1136/ard.2004.029660. Alirita 2023-04-06..

duke.edu

scholars.duke.edu

Aviña-Zubieta, J Antonio; Fergus To, Kateryna Vostretsova, Mary De Vera, Eric C Sayre, John M Esdaile (2017-06). “Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study”, Arthritis Care Res (Hoboken) (en) 69 (6), p. 849–856. doi:10.1002/acr.23018. Epub 2017 May 9. Alirita 2023-03-24..
Dall'Era, Maria; David Stone, Victoria Levesque, Miriam Cisternas, David Wofsy (2011-03). “Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide”, Arthritis Care Res (Hoboken) (en) 63 (3), p. 351–357. doi:10.1002/acr.20397. Epub 2010 Nov 15. Alirita 2023-04-05..

ima-press.net

mrj.ima-press.net

Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 18–19. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 18–19. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Лила, В.А. (2020). “Клинико-лабораторные взаимосвязи у пациентов с различными вариантами течения системной красной волчанки”, Современная ревматология (ru) (1), p. 26. doi:10.14412/1996-7012-2020-1-26-31. Alirita 20-08-2020..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 19–20. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология (ru) 2 (3), p. 20. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Краснова, Т. Н. (2008). “Поражение почек при системной красной волчанке: современные представления о патогенезе, клинике, подходы к лечению”, Современная ревматология 2 (3), p. 21. doi:10.14412/1996-7012-2008-483. Alirita 2023-03-20..
Лила, А.М.; Трофимов Е.А., Лила В.А. (2015). “Системная красная волчанка: особенности течения у беременных и варианты терапии”, Современная ревматология (ru) 9 (3), p. 45. doi:10.14412/1996-7012-2015-3-43-47. Alirita 20-08-2020..
Клюквина, Н.Г. (2013). “Опыт длительного применения белимумаба у больного системной красной волчанкой (описание случая)”, Современная ревматология (ru) 7 (2), p. 62–65. doi:10.14412/1996-7012-2013-2384. Alirita 20-08-2020..
Козловская, Н. Л.; С. К. Соловьев, Е. А. Асеева, Т. В. Попкова, Т. А. Панафидина, Е. Л. Насонов, А. М. Лила, А. А. Меснянкина, Н. Ю. Никишина (2020). “Обновленные рекомендации EULAR/ERA–EDTA 2019 г. по терапии волчаночного нефрита. Комментарии экспертов. Часть I” (ru) 14 (4), p. 8. doi:10.14412/1996-7012-2020-4-7-15. Alirita 2023-03-27..
Соколов, А. А.; А. С. Мануилов, С. Н. Бардаков, В. В. Тишко, А. Н. Бельских, О. Ю. Стрельникова, Т. В. Булгакова (2020). “Программная иммуносорбция с регенерацией сорбционных колонок при лечении волчаночного нефрита”, Современная ревматология (ru) 14 (3), p. 112. doi:10.14412/1996-7012-2020-3-111-116. Alirita 2023-04-05..

jrheum.org

Tselios, Konstantinos; Dafna D Gladman, Jiandong Su, Olga Ace, Murray B Urowitz (2017-12). “Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study”, The Journal of Rheumatology (en) 44 (12), p. 1841–1849. doi:10.3899/jrheum.161121. Epub 2017 Nov 1. Alirita 2023-03-24..
Touma, Zahi; Murray B Urowitz, Dominique Ibañez, Dafna D Gladman (2014-04). “Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment”, The Journal of Rheumatology (en) 41 (4), p. 688–697. doi:10.3899/jrheum.130005. Epub 2014 Jan 15. Alirita 2023-04-05..

kidney-international.org

Rabelink, T J; J J Zwaginga, H A Koomans, J J Sixma (1994-08). “Thrombosis and hemostasis in renal disease”, Kidney International (en) 46 (2), p. 287–296. doi:10.1038/ki.1994.274. Alirita 2023-03-24..

lww.com

journals.lww.com

Almaani, Salem; Alexa Meara, Brad H Rovin (2017-05-08). “Update on Lupus Nephritis”, Clinical Journal of the American Society of Nephrology (en) 12 (5), p. 825–835. doi:10.2215/CJN.05780616. Epub 2016 Nov 7. Alirita 2023-03-27..

mdpi.com

Duffy, Margaret; Shashank Jain, Nicholas Harrell, Neil Kothari, Alluru S Reddi (2015-10-07). “Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies”, Cells (en) 4 (4), p. 622–630. doi:10.3390/cells4040622. Alirita 2023-03-24..

mediar-press.net

rsp.mediar-press.net

Асеева, Е. А.; С. К. Соловьев, Т. В. Попкова, Н. Ю. Никишина, А. А. Меснянкина (2019). “Ведение пациентов с системной красной волчанкой в реальной клинической практике”, Научно-практическая ревматология (ru) 57 (2), p. 194. doi:10.14412/1995-4484-2019-191-196. Alirita 2023-04-05..

mediasphera.ru

Насонов, Е.Л.; Попкова Т.В., Новикова Д.С. (2016). “Сердечно-сосудистая патология при ревматических заболеваниях”, Терапевтический архив (ru) 88 (5), p. 4–12. doi:10.17116/terarkh20168854-12. Alirita 2023-03-24..

nature.com

Stohl, William; David M. Hilbert (9-01-2012). “The discovery and development of belimumab: the anti-BLyS-lupus connection”, Nature Biotechnology (en) 30 (1), p. 69–77. doi:10.1038/nbt.2076. Alirita 27-08-2020..

nih.gov

pubmed.ncbi.nlm.nih.gov

Bastian, H. M.; J. M. Roseman, G. McGwin Jr., G. S. Alarcón, A. W. Friedman, B. J. Fessler, B. A. Baethge, J. D. Reveille (2002). “Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis”, Lupus (en) 11 (3), p. 152–160. doi:10.1191/0961203302lu158oa. Alirita 2023-03-17..
Jakes, Rupert W.; Sang-Cheol Bae, Worawit Louthrenoo, Chi-Chiu Mok, Sandra V. Navarra, Namhee Kwon (2012-02). “Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality”, Arthritis Care & Research (en) 64 (2), p. 159–168. doi:10.1002/acr.20683. Alirita 2023-03-17..
Wakasugi, Daisuke; Takahisa Gono, Yasushi Kawaguchi, Masako Hara, Yumi Koseki, Yasuhiro Katsumata, Masanori Hanaoka, Hisashi Yamanaka (2012-01). “Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures” (en) 39 (1), p. 79–85. doi:10.3899/jrheum.110532. Alirita 2023-03-17..
Christopher-Stine, Lisa; Mark Siedner, Janice Lin, Mark Haas, Hemal Parekh, Michelle Petri, Derek M Fine (2007-02). “Renal biopsy in lupus patients with low levels of proteinuria” (en) 34 (2), p. 332–335. Alirita 2023-03-17..
Olson, Stephen W.; Jessica J Lee, Lisa K Prince, Thomas P Baker, Patricia Papadopoulos, Jess Edison, Kevin C Abbott (2013-10). “Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis”, Clinical Nephrology (en) 8 (10), p. 1702–1708. doi:10.2215/CJN.01910213. Alirita 2023-03-17..
Stojan, G.; M Petri (2016-07). “Anti-C1q in systemic lupus erythematosus”, Lupus (en) 25 (8), p. 873–877. doi:10.1177/0961203316645205. Alirita 2023-03-17..
Weixin, Hu; Yinghua Chen, Shaofan Wang, Hao Chen, Zhengzhao Liu, Caihong Zeng, Haitao Zhang, Zhihong Liu (2016-04-07). “Clinical-Morphological Features and Outcomes of Lupus Podocytopathy”, Clinical Nephrology (en) 11 (4), p. 585–592. doi:10.2215/CJN.06720615. Alirita 2023-03-17..
Di, Song; Li-hua Wu, Feng-mei Wang, Xiao-wei Yang, Di Zhu, Min Chen, Feng Yu, Gang Liu, Ming-hui Zhao (2013-01-15). “The spectrum of renal thrombotic microangiopathy in lupus nephritis”, Arthritis research & therapy (en) 15 (1). doi:10.1186/ar4142. Alirita 2023-03-17..
Bernatsky, S.; J-F Boivin, L Joseph, S Manzi, E Ginzler, D D Gladman, M Urowitz, P R Fortin, M Petri, S Barr, C Gordon, S-C Bae, D Isenberg, A Zoma, C Aranow, M-A Dooley, O Nived, G Sturfelt, K Steinsson, G Alarcón, J-L Senécal, M Zummer, J Hanly, S Ensworth, J Pope, S Edworthy, A Rahman, J Sibley, H El-Gabalawy, T McCarthy, Y St Pierre, A Clarke, R Ramsey-Goldman (2006 (Aŭgusto)). “Mortality in systemic lupus erythematosus”, Arthritis & Rheumatology (en) 54 (8). doi:10.1002/art.21955. Alirita 2023-03-17..
Almaani, Salem; Alexa Meara, Brad H Rovin (2017-05-08). “Update on Lupus Nephritis”, Clinical Journal of the American Society of Nephrology (en) 12 (5), p. 825–835. doi:10.2215/CJN.05780616. Epub 2016 Nov 7. Alirita 2023-03-27..
Bertsias, George K.; Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frederic A Houssiau, John P A Ioannidis, David A Isenberg, Cees G M Kallenberg, Liz Lightstone, Stephen D Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimir Tesar, Carlos Vasconcelos, Ronald F van Vollenhoven, Helena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T Boumpas; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012-11). “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Alirita 2023-03-22..
Ramos-Casals, Manuel; M. J. Soto, M. J. Cuadrado, M. A. Khamashta (08-2009). “Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases”, Lupus (en) (18(9)), p. 767–776. doi:10.1177/0961203309106174. Alirita 27-08-2020..
Stohl, William; David M. Hilbert (9-01-2012). “The discovery and development of belimumab: the anti-BLyS-lupus connection”, Nature Biotechnology (en) 30 (1), p. 69–77. doi:10.1038/nbt.2076. Alirita 27-08-2020..
Halpern, Wendy G.; Patrick Lappin, Thomas Zanardi, Wendy Cai, Marta Corcoran, John Zhong, Kevin P. Baker (06-2006). “Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects”, Toxicological Sciences (en) 91 (2), p. 586–599. doi:10.1093/toxsci/kfj148. Alirita 27-08-2020..
Navarra, Sandra V.; Renato M. Guzmán, Alberto E. Gallacher, Stephen Hall, Roger A. Levy, Renato E. Jimenez, Edmund K.-M. Li, Mathew Thomas, Ho-Youn Kim, Manuel G. León, Coman Tanasescu, Eugeny Nasonov, Joung-Liang Lan, Lilia Pineda, Z John Zhong, William Freimuth, Michelle A. Petri, BLISS-52 Study Group (26-02-2011). “Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial”, The Lancet (en) 377 (9767), p. 721–731. doi:10.1016/S0140-6736(10)61354-2. Alirita 27-08-2020..
Charlesworth, John A; David M Gracey, Bruce A Pussell (2008-02). “Adult nephrotic syndrome: non-specific strategies for treatment” (en) 13 (1), p. 45–50. doi:10.1111/j.1440-1797.2007.00890.x. Alirita 2023-03-24..
Duffy, Margaret; Shashank Jain, Nicholas Harrell, Neil Kothari, Alluru S Reddi (2015-10-07). “Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies”, Cells (en) 4 (4), p. 622–630. doi:10.3390/cells4040622. Alirita 2023-03-24..
Rabelink, T J; J J Zwaginga, H A Koomans, J J Sixma (1994-08). “Thrombosis and hemostasis in renal disease”, Kidney International (en) 46 (2), p. 287–296. doi:10.1038/ki.1994.274. Alirita 2023-03-24..
Aviña-Zubieta, J Antonio; Fergus To, Kateryna Vostretsova, Mary De Vera, Eric C Sayre, John M Esdaile (2017-06). “Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study”, Arthritis Care Res (Hoboken) (en) 69 (6), p. 849–856. doi:10.1002/acr.23018. Epub 2017 May 9. Alirita 2023-03-24..
Tselios, Konstantinos; Dafna D Gladman, Jiandong Su, Olga Ace, Murray B Urowitz (2017-12). “Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study”, The Journal of Rheumatology (en) 44 (12), p. 1841–1849. doi:10.3899/jrheum.161121. Epub 2017 Nov 1. Alirita 2023-03-24..
(2012-11) “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Alirita 2023-03-27..
Dall'Era, Maria; Miriam G Cisternas, Dawn E Smilek, Laura Straub, Frédéric A Houssiau, Ricard Cervera, Brad H Rovin, Meggan Mackay (2015-05). “Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort”, Arthritis & Rheumatology (en) 67 (5), p. 1305–1313. doi:10.1002/art.39026. Alirita 2023-04-05..
Tamirou, Farah; David D'Cruz, Shirish Sangle, Philippe Remy, Carlos Vasconcelos, Christoph Fiehn, Maria del Mar Ayala Guttierez, Inge-Magrethe Gilboe, Maria Tektonidou, Daniel Blockmans, Isabelle Ravelingien, Véronique le Guern, Geneviève Depresseux, Loïc Guillevin, Ricard Cervera, Frédéric A Houssiau; MAINTAIN Nephritis Trial Group (2016-03). “Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis”, Annals of Rheumatic Diseases (en), p. 526–531. doi:10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10. Alirita 2023-04-05..
Tamirou, Farah; Bernard R Lauwerys, Maria Dall'Era, Meggan Mackay, Brad Rovin, Ricard Cervera, Frédéric A Houssiau; MAINTAIN Nephritis Trial Investigators (2015-11-12). “A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial”, Lupus Science & Medicine (en) 2 (1), p. e000123. doi:10.1136/lupus-2015-000123. eCollection 2015. Alirita 2023-04-05..
Mackay, Meggan; Maria Dall'Era, Joanna Fishbein, Kenneth Kalunian, Martin Lesser, Jorge Sanchez-Guerrero, Deborah M Levy, Earl Silverman, Michelle Petri, Cristina Arriens, Edmund J Lewis, Stephen M Korbet, Fabrizio Conti, Vladimir Tesar, Zdenka Hruskova, Eduardo F Borba, Eloisa Bonfa, Tak Mao Chan, Manish Rathi, K L Gupta, Vivekanand Jha, Sarfaraz Hasni, Melissa R West, Neil Solomons, Frederic A Houssiau, Juanita Romero-Diaz, Juan Mejia-Vilet, Brad H Rovin (2019-03). “Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes”, Arthritis & Rheumatology (en) 71 (3), p. 411–419. doi:10.1002/art.40724. Epub 2019 Feb 1. Alirita 2023-04-05..
Dall'Era, Maria; David Stone, Victoria Levesque, Miriam Cisternas, David Wofsy (2011-03). “Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide”, Arthritis Care Res (Hoboken) (en) 63 (3), p. 351–357. doi:10.1002/acr.20397. Epub 2010 Nov 15. Alirita 2023-04-05..
Dall'Era, Maria; Victoria Levesque, Neil Solomons, Matt Truman, David Wofsy (2015-05-20). “Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome”, Lupus Science & Medicine (en) 2 (1), p. e000089. doi:10.1136/lupus-2015-000089. eCollection 2015. Alirita 2023-04-05..
Touma, Zahi; Murray B Urowitz, Dominique Ibañez, Dafna D Gladman (2014-04). “Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment”, The Journal of Rheumatology (en) 41 (4), p. 688–697. doi:10.3899/jrheum.130005. Epub 2014 Jan 15. Alirita 2023-04-05..
Padmanabhan, Anand; Laura Connelly-Smith, Nicole Aqui, Rasheed A Balogun, Reinhard Klingel, Erin Meyer, Huy P Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D Zantek, Nancy M Dunbar, Guest Editor Joseph Schwartz (2019-06). “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue”, The Journal of Clinical Apheresis (en) 34 (3), p. 171–354. doi:10.1002/jca.21705. Alirita 2023-04-05..
Bertsias, George K.; Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frederic A Houssiau, John P A Ioannidis, David A Isenberg, Cees G M Kallenberg, Liz Lightstone, Stephen D Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimir Tesar, Carlos Vasconcelos, Ronald F van Vollenhoven, Helena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T Boumpas; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012-11). “Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis”, Annals of Rheumatic Diseases (en) 71 (11), p. 1771–1782. doi:10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Alirita 2023-04-05..
Li, MinXia; YuanDa Wang, Qiang Qiu, RiBao Wei, YuWei Gao, Li Zhang, Yong Wang, XueGuang Zhang, XiangMei Chen (2016-08). “Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis”, The Journal of Clinical Apheresis (en) 31 (4), p. 375–380. doi:10.1002/jca.21408. Epub 2015 May 28. Alirita 2023-04-05..
Yamaji, Ken; Young-Joon Kim, Hiroshi Tsuda, Yoshinari Takasaki (2008-08). “Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis”, Therapeutic Apheresis and Dialysis (en) 12 (4), p. 298–305. doi:10.1111/j.1744-9987.2008.00591.x. Alirita 2023-04-06..
Stefanutti, Claudia; Antonio Vivenzio, Serafina Di Giacomo, Maura Mareri, Fulvia Ceccarelli, Guido Valesini (2005). “Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone”, BioDrugs (en) 19 (2), p. 129–133. doi:10.2165/00063030-200519020-00004. Alirita 2023-04-06..
Braun, N.; C Erley, R Klein, I Kötter, J Saal, T Risler (2000-09). “Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus”, Nephrology Dialysis Transplantation (en) 15 (9), p. 1367–1372. doi:10.1093/ndt/15.9.1367. Alirita 2023-04-06..
Stummvoll, Georg H.; Sabine Schmaldienst, Josef S Smolen, Kurt Derfler, Peter Biesenbach (2012-02). “Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity”, Nephrology Dialysis Transplantation (en) 27 (2), p. 618–626. doi:10.1093/ndt/gfr239. Epub 2011 May 26. Alirita 2023-04-06..

ncbi.nlm.nih.gov

Gustafsson, Johanna T.; Marie Herlitz Lindberg, Iva Gunnarsson, Susanne Pettersson, Kerstin Elvin, John Öhrvik, Anders Larsson, Kerstin Jensen-Urstad, Elisabet Svenungsson (2017). “Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls”, PLOS ONE (en) 12 (4). doi:10.1371/journal.pone.0174572. Alirita 2023-03-24..
Stummvoll, G.; M Aringer, J Smolen, S Schmaldienst, E Jimenez-Boj, W Horl, W Graninger, K Derfler (2005-07). “IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study”, Annals of Rheumatic Diseases (en) 64 (7), p. 1015–1021. doi:10.1136/ard.2004.029660. Alirita 2023-04-06..

oup.com

academic.oup.com

Braun, N.; C Erley, R Klein, I Kötter, J Saal, T Risler (2000-09). “Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus”, Nephrology Dialysis Transplantation (en) 15 (9), p. 1367–1372. doi:10.1093/ndt/15.9.1367. Alirita 2023-04-06..
Stummvoll, Georg H.; Sabine Schmaldienst, Josef S Smolen, Kurt Derfler, Peter Biesenbach (2012-02). “Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity”, Nephrology Dialysis Transplantation (en) 27 (2), p. 618–626. doi:10.1093/ndt/gfr239. Epub 2011 May 26. Alirita 2023-04-06..

plos.org

journals.plos.org

Gustafsson, Johanna T.; Marie Herlitz Lindberg, Iva Gunnarsson, Susanne Pettersson, Kerstin Elvin, John Öhrvik, Anders Larsson, Kerstin Jensen-Urstad, Elisabet Svenungsson (2017). “Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls”, PLOS ONE (en) 12 (4). doi:10.1371/journal.pone.0174572. Alirita 2023-03-24..

regionh.dk

research.regionh.dk

Hermansen, Marie-Louise; Jesper Lindhardsen, Christian Torp-Pedersen, Mikkel Faurschou, Søren Jacobsen (2017). “The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study”, Rheumatology (Oxford, England) (en) 56 (5), p. 709–715. doi:10.1093/rheumatology/kew475. Alirita 2023-03-24..

researchgate.net

van Vollenhoven, Ronald; M. J. Soto, M. J. Cuadrado, M. A. Khamashta (10-2011). “Rituximab — Shadow, illusion or light?”, Autoimmunity reviews (en) (11(8)), p. 563–567. doi:10.1016/j.autrev.2011.10.013. Alirita 27-08-2020..

rmj.ru

Соловьев, С.К.; Асеева Е.А., Торгашина А.В. (2010). “Интенсифицированная терапия аутоиммунных ревматических заболеваний”, Русский медицинский журнал (ru) 18 (11), p. 748–751. Alirita 2023-03-23..

rusvrach.ru

nephro.rusvrach.ru

Козловская, Л.; Бобкова И., Фомин В. (2010). “Почечные отеки: механизмы развития, принципы лечения”, Врач (ru), p. 14–16. Alirita 2023-03-24..

springer.com

Stefanutti, Claudia; Antonio Vivenzio, Serafina Di Giacomo, Maura Mareri, Fulvia Ceccarelli, Guido Valesini (2005). “Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone”, BioDrugs (en) 19 (2), p. 129–133. doi:10.2165/00063030-200519020-00004. Alirita 2023-04-06..

vrachjournal.ru

Козловская, Л.; Бобкова И., Фомин В. (2010). “Почечные отеки: механизмы развития, принципы лечения”, Врач (ru), p. 14–16. Alirita 2023-03-24..

wiley.com

onlinelibrary.wiley.com

Furie, Richard; Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sanchez‐Guerrero, Andreas Schwarting, Joan T. Merrill, W. Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William Freimuth, Ronald F. van Vollenhoven, BLISS‐76 Study Group (12-2011). “A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus†”, Arthritis & Rheumatology (en) 63 (12), p. 3918–3930. doi:10.1002/art.30613. Alirita 27-08-2020..
Dall'Era, Maria; Miriam G Cisternas, Dawn E Smilek, Laura Straub, Frédéric A Houssiau, Ricard Cervera, Brad H Rovin, Meggan Mackay (2015-05). “Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort”, Arthritis & Rheumatology (en) 67 (5), p. 1305–1313. doi:10.1002/art.39026. Alirita 2023-04-05..
Mackay, Meggan; Maria Dall'Era, Joanna Fishbein, Kenneth Kalunian, Martin Lesser, Jorge Sanchez-Guerrero, Deborah M Levy, Earl Silverman, Michelle Petri, Cristina Arriens, Edmund J Lewis, Stephen M Korbet, Fabrizio Conti, Vladimir Tesar, Zdenka Hruskova, Eduardo F Borba, Eloisa Bonfa, Tak Mao Chan, Manish Rathi, K L Gupta, Vivekanand Jha, Sarfaraz Hasni, Melissa R West, Neil Solomons, Frederic A Houssiau, Juanita Romero-Diaz, Juan Mejia-Vilet, Brad H Rovin (2019-03). “Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes”, Arthritis & Rheumatology (en) 71 (3), p. 411–419. doi:10.1002/art.40724. Epub 2019 Feb 1. Alirita 2023-04-05..
Padmanabhan, Anand; Laura Connelly-Smith, Nicole Aqui, Rasheed A Balogun, Reinhard Klingel, Erin Meyer, Huy P Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D Zantek, Nancy M Dunbar, Guest Editor Joseph Schwartz (2019-06). “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue”, The Journal of Clinical Apheresis (en) 34 (3), p. 171–354. doi:10.1002/jca.21705. Alirita 2023-04-05..
Li, MinXia; YuanDa Wang, Qiang Qiu, RiBao Wei, YuWei Gao, Li Zhang, Yong Wang, XueGuang Zhang, XiangMei Chen (2016-08). “Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis”, The Journal of Clinical Apheresis (en) 31 (4), p. 375–380. doi:10.1002/jca.21408. Epub 2015 May 28. Alirita 2023-04-05..
Yamaji, Ken; Young-Joon Kim, Hiroshi Tsuda, Yoshinari Takasaki (2008-08). “Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis”, Therapeutic Apheresis and Dialysis (en) 12 (4), p. 298–305. doi:10.1111/j.1744-9987.2008.00591.x. Alirita 2023-04-06..